Skip to content

Precigen PGEN Total Cost of Revenue

Total Cost of Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.42B+12.8%
Gilead Sciences logo
Gilead SciencesGILD
$1.45B-6.2%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$1.32M+21.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$9.94M+277%
ALN
Alnylam PharmaceuticalsALNY
$207.52M+196%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsSold.

The official record: Precigen’s 10-Q, filed August 13, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.